A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis
N.E. Lane, Bang‐Gee Hsu, Jennifer Visich, B. Xie, A. Khan, J. Dananberg
Topics & Concepts
OsteoarthritisWOMACMedicinePlaceboClinical endpointPhysical therapyRandomized controlled trialClinical trialKnee painInternal medicineAnesthesiaAlternative medicinePathologyCytokine Signaling Pathways and InteractionsOsteoarthritis Treatment and MechanismsCancer, Stress, Anesthesia, and Immune Response